Mehmood Khan
Mehmood Khan, M.D. is Chief Executive Officer, Global Nutrition Group and Chief Scientific Officer. He was appointed Senior Vice President and Chief Scientific Officer when he joined PepsiCo in 2008, and was given the additional responsibility of Chief Executive Officer, Global Nutrition Group in October 2010.
In his role as Chief Executive Officer, Global Nutrition Group, Dr. Khan will establish PepsiCo as the leading provider of Good-for-You (GFY) foods and beverages that are great tasting, wholesome, accessible, affordable and advantaged by science. Currently, PepsiCo has a GFY product portfolio of $10 billion in revenues and through the establishment of the Global Nutrition Group, this business is expected to grow to $30 billion by 2020. Dr. Khan retains the responsibility for the company’s research and development organization.
As Chief Scientific Officer, Dr. Khan guides the company’s long-term research strategy and agenda for business opportunities. He provides global leadership and support to R&D for all PepsiCo divisions in the areas of enterprise research planning, R&D portfolio management, next generation technologies, nutritional standards, food safety and regulation, and quality assurance.
During the time Dr. Khan has served in this CSO role, PepsiCo has expanded investment in R&D, recruiting highly regarded clinical scientists, global health policy makers and medical experts and has launched research projects with leading universities and other institutions around the world.
Dr. Khan previously served as President of Takeda Pharmaceuticals Global Research and Development Center. He built the company's U.S. Medical Affairs and Global Medical Affairs functions, and helped develop the strong, scientific basis for launching the company’s major products as President of U.S. and European drug development.
As an M.D. with specialties in Internal Medicine and Endocrinology, Dr. Khan has extensive academic and clinical experience. He also served at the Mayo Clinic until 2003 as the Director of the Diabetes, Endocrinology and Nutrition Clinical Trial Unit and as Consultant Physician in Endocrinology. Dr. Khan spent six years with the Department of Food, Sciences and Nutrition at the University of Minnesota. He also served as division chief of Endocrinology, Metabolism and Nutrition at one of the main teaching hospitals of the University of Minnesota Medical School.
Dr. Khan earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology in the Department of Medicine, University of Minnesota, Minneapolis. He has also served on numerous state and national committees of the American Diabetes Association, the Minneapolis Medical Research Foundation and the National Institutes of Health. Additionally, Dr. Khan held several visiting professorships and has published extensively. He currently serves as a member of the Board of Governors, New York Academy of Sciences.
Dr. Khan will be based in Chicago.